Literature DB >> 12602530

Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas.

P Viacava1, M Gasperi, G Acerbi, L Manetti, E Cecconi, A G Bonadio, A G Naccarato, F Acerbi, G Parenti, I Lupi, M Genovesi, E Martino.   

Abstract

Microvessel density (MVD) represents a measure of angiogenesis and may be used as an indicator of neoplastic aggressiveness. Vascular endothelial growth factor (VEGF) plays a pivotal role as angiogenic promoter by stimulating endothelial cell proliferation and migration and enhancing vascular permeability. The aim of this study was to investigate MVD and VEGF expression in human pituitary adenomas and normal pituitary gland tissues by immunohistochemistry, and to correlate data with clinical characteristics. Fragments from 46 pituitary adenomas (18 non-functioning, 12 ACTH-secreting, 12 GH-secreting, 4 PRL-secreting) and 19 specimens of normal anterior pituitary gland obtained at surgery were evaluated. MVD in normal anterior pituitary was significantly higher than in tumors (69.2 +/- 28.5 vs 29.3 +/- 19.7; p < 0.0001). Within adenomas, no difference was found in MVD when different histotype, size, sex, age, rate of recurrence or medical pre-surgical treatment were considered. The degree of vascularity was somewhat related only to clinical invasiveness, as evaluated by pre-surgical MRI grading (grade 0 p < 0.05 vs grade 1 and vs grade 2). No statistically significant difference in VEGF expression was found between normal tissue and adenomas and among tumors of different histotype (p = 0.3978). Size, sex, age, rate of recurrence and medical pre-surgical treatment did not influence VEGF expression. No correlation was found between MVD and VEGF expression. In conclusion, MVD was reduced in pituitary adenomas with respect to normal gland. VEGF expression is however well preserved in adenomas and this might contribute to adequate tumoral vascular supply with complex mechanisms other than endothelial cells proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602530     DOI: 10.1007/BF03345118

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

2.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.

Authors:  N Ferrara; D W Leung; G Cachianes; J Winer; W J Henzel
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer.

Authors:  M Volm; R Koomägi; J Mattern
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

5.  Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.

Authors:  P Lohrer; J Gloddek; U Hopfner; M Losa; E Uhl; U Pagotto; G K Stalla; U Renner
Journal:  Neuroendocrinology       Date:  2001-08       Impact factor: 4.914

6.  Different features of angiogenesis between ovarian and breast carcinoma.

Authors:  K Nakayama; A Kanzaki; Y Takebayashi; M Toi; H Bando; T Nabei; K Miyazaki; M Fukumoto
Journal:  Cancer Lett       Date:  2001-09-20       Impact factor: 8.679

7.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

8.  Expression of vascular endothelial growth factor in human brain tumors.

Authors:  R Nishikawa; S Y Cheng; R Nagashima; H J Huang; W K Cavenee; M Matsutani
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

9.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; J A Wass; A L Harris
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  38 in total

1.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue.

Authors:  Antonio Di Ieva; Fabio Grizzi; Paolo Gaetani; Umberto Goglia; Manfred Tschabitscher; Pietro Mortini; Riccardo Rodriguez y Baena
Journal:  Neurosurg Rev       Date:  2008-03-08       Impact factor: 3.042

3.  VEGF and CD31 association in pituitary adenomas.

Authors:  Carolina Cristina; María Inés Perez-Millan; Guillermina Luque; Raúl Ariel Dulce; Gustavo Sevlever; Silvia Inés Berner; Damasia Becu-Villalobos
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

4.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

Review 5.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 6.  The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

7.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Silvina Gutiérrez; Félix Daniel Roth; Agustín Aoki; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

8.  Definition of the microvascular pattern of the normal human adult mammary gland.

Authors:  Antonio G Naccarato; Paolo Viacava; Guido Bocci; Giovanni Fanelli; Paolo Aretini; Antonino Lonobile; Giancarlo Montruccoli; Generoso Bevilacqua
Journal:  J Anat       Date:  2003-12       Impact factor: 2.610

9.  Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach.

Authors:  N Sandow; W Klene; U Elbelt; C J Strasburger; P Vajkoczy
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

10.  Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.

Authors:  Ryutaro Nomura; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-03-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.